Gut Liver.  2017 Jan;11(1):3-4. 10.5009/gnl16574.

Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?

Affiliations
  • 1Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea. cseun@hanyang.ac.kr

Abstract

No abstract available.


MeSH Terms

Antibodies, Monoclonal
*Drug Monitoring
Humans
Inflammatory Bowel Diseases
Infliximab
*Tumor Necrosis Factor-alpha
Antibodies, Monoclonal
Tumor Necrosis Factor-alpha
Infliximab
Full Text Links
  • GNL
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr